Related Experiment Video
Updated: Apr 23, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
1.9K
Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression
Leslie Guéry1, Juan Dubrot1, Carla Lippens1
1Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland.
Cancer Research
|September 26, 2014
Summary
Plasmacytoid dendritic cells (pDCs) presenting antigens activate Th17 cell differentiation. This immune response is crucial for recruiting cytotoxic T lymphocytes (CTLs) to tumors, promoting tumor regression.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Plasmacytoid dendritic cells (pDCs) are key immune cells that produce type I interferon and cytokines.
- pDCs influence T-cell responses and differentiation, exhibiting either tolerogenic or immunogenic properties based on the immune environment.
- T-helper 17 (Th17) cells play a critical role in adaptive immunity and host defense.
Purpose of the Study:
- To investigate the role of antigen-presenting pDCs in Th17 cell differentiation.
- To determine the impact of pDC-mediated Th17 responses on anti-tumor immunity.
- To explore the therapeutic potential of activating pDCs for cancer treatment.
Main Methods:
- Utilized genetically modified mice lacking MHCII on pDCs to assess Th17 responses.
- Administered CpG-B and tumor antigens to mice to study pDC activation and anti-tumor immunity.
- Analyzed T-cell differentiation, immune cell infiltration in tumors, and tumor growth.
Main Results:
- CpG-activated pDCs significantly promote Th17 cell differentiation.
- Defective Th17 responses were observed in mice lacking MHCII on pDCs, leading to impaired tumor infiltration of Th17 cells and other leukocytes, including cytotoxic T lymphocytes (CTLs).
- This impairment resulted in increased tumor growth, while immunization with tumor antigen and CpG-B led to Th17-mediated anti-tumor immunity and tumor regression.
Conclusions:
- Antigen-presenting pDCs are crucial for promoting Th17 cell differentiation and anti-tumor immunity.
- pDC-mediated Th17 responses are essential for effective anti-tumor immunity by facilitating CTL recruitment into tumors.
- Targeting pDC activation holds promise for enhancing anti-tumor immune responses and cancer therapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K